Triplebar isn't just another biotech startup—it's a precision instrument for evolution. With a tiny team of 29 engineers and scientists, they've raised $21M to industrialize the very process of biological discovery, turning the slow, unpredictable art of protein engineering into a fast, measurable science.

"Triplebar isn't building tools for biotech—they're building the operating system for evolution itself."

The technology stack tells its own story. They're using jQuery, Tailwind CSS, Bootstrap, and Cloudflare—standard web tools for a company focused on the backend science, not frontend flash. The absence of structured data is telling: Triplebar isn't optimizing for search engines; they're building for scientists and partners who already know what they're looking for.

• Evolutionary Intelligence as core IP: They've weaponized directed evolution for industrial-scale protein engineering
• Lean execution: $21M raised with only 29 employees suggests capital efficiency rare in biotech
• Niche authority: 42% direct traffic indicates strong word-of-mouth in specialized circles
• Leadership depth: Maria Cho and Jeremy Agresti bring both scientific and founder credibility